156 related articles for article (PubMed ID: 24070538)
1. Risky driving and pedunculopontine nucleus-thalamic cholinergic denervation in Parkinson disease.
Weathers SP; Kotagal V; Bohnen NI; Chou KL
Parkinsonism Relat Disord; 2014 Jan; 20(1):13-6. PubMed ID: 24070538
[TBL] [Abstract][Full Text] [Related]
2. Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease.
Müller ML; Albin RL; Kotagal V; Koeppe RA; Scott PJ; Frey KA; Bohnen NI
Brain; 2013 Nov; 136(Pt 11):3282-9. PubMed ID: 24056537
[TBL] [Abstract][Full Text] [Related]
3. History of falls in Parkinson disease is associated with reduced cholinergic activity.
Bohnen NI; Müller ML; Koeppe RA; Studenski SA; Kilbourn MA; Frey KA; Albin RL
Neurology; 2009 Nov; 73(20):1670-6. PubMed ID: 19917989
[TBL] [Abstract][Full Text] [Related]
4. Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease.
Kotagal V; Albin RL; Müller ML; Koeppe RA; Chervin RD; Frey KA; Bohnen NI
Ann Neurol; 2012 Apr; 71(4):560-8. PubMed ID: 22522445
[TBL] [Abstract][Full Text] [Related]
5. Gait speed in Parkinson disease correlates with cholinergic degeneration.
Bohnen NI; Frey KA; Studenski S; Kotagal V; Koeppe RA; Scott PJ; Albin RL; Müller ML
Neurology; 2013 Oct; 81(18):1611-6. PubMed ID: 24078735
[TBL] [Abstract][Full Text] [Related]
6. Thalamic cholinergic innervation is spared in Alzheimer disease compared to parkinsonian disorders.
Kotagal V; Müller ML; Kaufer DI; Koeppe RA; Bohnen NI
Neurosci Lett; 2012 Apr; 514(2):169-72. PubMed ID: 22414859
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of cholinergic denervation in Parkinson's disease without dementia.
Bohnen NI; Müller ML; Kotagal V; Koeppe RA; Kilbourn MR; Gilman S; Albin RL; Frey KA
J Cereb Blood Flow Metab; 2012 Aug; 32(8):1609-17. PubMed ID: 22569194
[TBL] [Abstract][Full Text] [Related]
8. Gender differences in cholinergic and dopaminergic deficits in Parkinson disease.
Kotagal V; Albin RL; Müller ML; Koeppe RA; Frey KA; Bohnen NI
J Neural Transm (Vienna); 2013 Oct; 120(10):1421-4. PubMed ID: 23532360
[TBL] [Abstract][Full Text] [Related]
9. Extra-nigral pathological conditions are common in Parkinson's disease with freezing of gait: an in vivo positron emission tomography study.
Bohnen NI; Frey KA; Studenski S; Kotagal V; Koeppe RA; Constantine GM; Scott PJ; Albin RL; Müller ML
Mov Disord; 2014 Aug; 29(9):1118-24. PubMed ID: 24909584
[TBL] [Abstract][Full Text] [Related]
10. Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects.
Bohnen NI; Albin RL; Müller ML; Petrou M; Kotagal V; Koeppe RA; Scott PJ; Frey KA
JAMA Neurol; 2015 Feb; 72(2):194-200. PubMed ID: 25506674
[TBL] [Abstract][Full Text] [Related]
11. Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease.
Bohnen NI; Müller ML; Kotagal V; Koeppe RA; Kilbourn MA; Albin RL; Frey KA
Brain; 2010 Jun; 133(Pt 6):1747-54. PubMed ID: 20413575
[TBL] [Abstract][Full Text] [Related]
12. An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease.
Pienaar IS; Harrison IF; Elson JL; Bury A; Woll P; Simon AK; Dexter DT
Brain Struct Funct; 2015 Jan; 220(1):479-500. PubMed ID: 24292256
[TBL] [Abstract][Full Text] [Related]
13. Clinical markers for identifying cholinergic deficits in Parkinson's disease.
Müller ML; Bohnen NI; Kotagal V; Scott PJ; Koeppe RA; Frey KA; Albin RL
Mov Disord; 2015 Feb; 30(2):269-73. PubMed ID: 25393613
[TBL] [Abstract][Full Text] [Related]
14. Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease.
Bohnen NI; Kotagal V; Müller ML; Koeppe RA; Scott PJ; Albin RL; Frey KA; Petrou M
Parkinsonism Relat Disord; 2014 Dec; 20(12):1394-8. PubMed ID: 25454317
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic Nigrostriatal Connectivity in Early Parkinson Disease: In Vivo Neuroimaging Study of
Sanchez-Catasus CA; Bohnen NI; Yeh FC; D'Cruz N; Kanel P; Müller MLTM
J Nucl Med; 2021 Apr; 62(4):545-552. PubMed ID: 32859707
[TBL] [Abstract][Full Text] [Related]
16. Neuroimaging and clinical predictors of fatigue in Parkinson disease.
Chou KL; Kotagal V; Bohnen NI
Parkinsonism Relat Disord; 2016 Feb; 23():45-9. PubMed ID: 26683744
[TBL] [Abstract][Full Text] [Related]
17. Role of pedunculopontine cholinergic neurons in the vulnerability of nigral dopaminergic neurons in Parkinson's disease.
Bensaid M; Michel PP; Clark SD; Hirsch EC; François C
Exp Neurol; 2016 Jan; 275 Pt 1():209-19. PubMed ID: 26571193
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial DNA changes in pedunculopontine cholinergic neurons in Parkinson disease.
Bury AG; Pyle A; Elson JL; Greaves L; Morris CM; Hudson G; Pienaar IS
Ann Neurol; 2017 Dec; 82(6):1016-1021. PubMed ID: 29149768
[TBL] [Abstract][Full Text] [Related]
19. The pedunculopontine nucleus is related to visual hallucinations in Parkinson's disease: preliminary results of a voxel-based morphometry study.
Janzen J; van 't Ent D; Lemstra AW; Berendse HW; Barkhof F; Foncke EM
J Neurol; 2012 Jan; 259(1):147-54. PubMed ID: 21717194
[TBL] [Abstract][Full Text] [Related]
20. Cholinergic systems, attentional-motor integration, and cognitive control in Parkinson's disease.
Albin RL; van der Zee S; van Laar T; Sarter M; Lustig C; Muller MLTM; Bohnen NI
Prog Brain Res; 2022; 269(1):345-371. PubMed ID: 35248201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
